The trial aims to investigate a new orally administered Etvax® vaccine, which is hoped to protect from so called ETEC bacteria. ETEC, a type of E. Coli, is one of the most common causes of traveller’s diarrhea and it has a global role in the diarrhea cases in children in the developing countries.
The trial will be conducted by Helsinki University, Gothenburg University and Johns Hopkins University and it is sponsored by Scandinavian Biopharma and funded by U.S. sponsors. Medfiles and Yhtyneet Medix Laboratoriot are together contributing to the trial by bringing their vast expertise in clinical trials and laboratory analytics.
Medfiles is proud to be a part of this groundbreaking clinical trial.
Helsingin Sanomat (In Finnish)